A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers

The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

NCT05977101 ·Status: UNKNOWN ·Phase: NA

Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

NCT05148962 ·Status: COMPLETED ·Phase: PHASE1

Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19

NCT05656443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

NCT05547256 ·Status: UNKNOWN ·Phase: NA

Phase 1 Study of MGD010 in Healthy Subjects

NCT02376036 ·Status: COMPLETED ·Phase: PHASE1

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

NCT05550142 ·Status: UNKNOWN ·Phase: NA

A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

NCT04691180 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

NCT06167915 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

NCT05997290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

NCT07205796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

NCT04479631 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

NCT05664932 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years

NCT05716347 ·Status: TERMINATED ·Phase: EARLY_PHASE1

A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

NCT05907044 ·Status: COMPLETED ·Phase: NA

Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)

NCT04679909 ·Status: COMPLETED ·Phase: PHASE1

Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test

NCT04808921 ·Status: WITHDRAWN ·Phase: NA

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

NCT04368728 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults

NCT04785144 ·Status: COMPLETED ·Phase: PHASE1

GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)

NCT05182567 ·Status: UNKNOWN ·Phase: PHASE1

The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults

NCT05148091 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults

NCT06194318 ·Status: COMPLETED ·Phase: PHASE1

Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

NCT05258669 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001

NCT05125926 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

NCT04787211 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

NCT04479644 ·Status: COMPLETED ·Phase: PHASE1